Detalhe da pesquisa
1.
Targeting intracellular WT1 in AML with a novel RMF-peptide-MHC-specific T-cell bispecific antibody.
Blood
; 138(25): 2655-2669, 2021 12 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34280257
2.
Fusion of Bacterial Flagellin to a Dendritic Cell-Targeting αCD40 Antibody Construct Coupled With Viral or Leukemia-Specific Antigens Enhances Dendritic Cell Maturation and Activates Peptide-Responsive T Cells.
Front Immunol
; 11: 602802, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33281829
3.
Toll-like receptor 7/8-matured RNA-transduced dendritic cells as post-remission therapy in acute myeloid leukaemia: results of a phase I trial.
Clin Transl Immunology
; 9(3): e1117, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32153780
4.
Targeting LAG-3 and PD-1 to Enhance T Cell Activation by Antigen-Presenting Cells.
Front Immunol
; 9: 385, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29535740